Cellular Dynamics Q4 Revenues up 45 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Cellular Dynamics said after the close of the market on Monday that its revenues for the fourth quarter increased 45 percent year over year.

The Madison, Wis.-based developer of fully functional human cells for research applications reported total revenues of $4.2 million for the three months ended Dec. 31, 2013, up from $2.9 million in the year-ago fourth quarter. Product sales rose 9 percent to $2.5 million from $2.3 million, while revenues from collaborations, partnerships, and other sources more than doubled to $1.7 million from $657,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.